Gastrointestinal (GI) bleeding was observed in 3% of hospitalized COVID-19 patients, and a bleed developing during hospitalization was tied to greater mortality, a large New York cohort study found.
Anticoagulation or antiplatelet agents were not risk factors for GI bleeding but neither did they protect against them, reported Arvind J. Trindade, MD, of the Feinstein Institutes for Medical Research at Northwell Health in Manhasset, New York, and colleagues.